当前位置:首页 - 行情中心 - 毕得医药(688073) - 财务分析

毕得医药

(688073)

  

流通市值:22.21亿  总市值:46.68亿
流通股本:4323.42万   总股本:9088.29万

毕得医药(688073)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.31亿元,每股收益0.34元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益203337.09万元,未分配利润29061.03万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产266927.19万元,负债63590.11万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入296,374,647.621,102,010,333.61811,377,889.62532,207,309.99
营业总成本245,523,164.31931,884,986.72696,947,815.87456,333,477.22
营业利润43,139,300.44148,334,349.56102,287,565.1764,074,794.65
利润总额43,349,042.99148,018,153.98102,391,559.7964,254,167.56
净利润30,693,093.12117,426,163.5183,853,892.851,839,064.55
其他综合收益724,099.55-1,641,272.743,372,706.74376,362.85
综合收益总额31,417,192.67115,784,890.7787,226,599.5452,215,427.4
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,707,237,377.892,208,723,169.252,160,696,619.692,177,018,736.88
非流动资产合计962,034,554.98209,311,949.15191,468,793.21137,128,286.29
资产总计2,669,271,932.872,418,035,118.42,352,165,412.92,314,147,023.17
流动负债合计593,692,231.04345,761,323.6316,007,191.11296,014,511.51
非流动负债合计42,208,825.2345,151,331.1638,185,293.3542,970,044.61
负债合计635,901,056.27390,912,654.76354,192,484.46338,984,556.12
归属于母公司股东权益合计2,033,370,876.62,027,122,463.641,997,972,928.441,975,162,467.05
股东权益合计2,033,370,876.62,027,122,463.641,997,972,928.441,975,162,467.05
负债和股东权益合计2,669,271,932.872,418,035,118.42,352,165,412.92,314,147,023.17
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计286,980,156.391,293,712,783.17889,986,877.02591,673,701.61
经营活动现金流出小计279,883,597.41,135,400,077.66789,436,921.65501,996,272.43
经营活动产生的现金流量净额7,096,558.99158,312,705.51100,549,955.3789,677,429.18
投资活动现金流入小计96,578,027.77694,277,207.16360,254,145.57143,211,618.4
投资活动现金流出小计838,293,599.56852,754,867.09710,003,767.26409,897,389.54
投资活动产生的现金流量净额-741,715,571.79-158,477,659.93-349,749,621.69-266,685,771.14
筹资活动现金流入小计231,501,858.62104,944,888.52112,168,202.1774,733,673.07
筹资活动现金流出小计46,780,197.83271,787,057.28247,785,514.5215,498,037.29
筹资活动产生的现金流量净额184,721,660.79-166,842,168.76-135,617,312.33-140,764,364.22
汇率变动对现金及现金等价物的影响2,458,750.34-1,442,233.01-1,339,636.09-101,748.5
现金及现金等价物净增加额-547,438,601.67-168,449,356.19-386,156,614.74-317,874,454.68
期末现金及现金等价物余额549,182,096.581,096,620,698.25878,913,439.7947,195,599.76
最新报告期:2025-05-09
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券陈竹,王凯旋,韩世通1.571.892.222025-05-09
浙商证券王帅,胡隽扬1.602.002.552025-05-06
华创证券郑辰1.601.972.362025-05-05
开源证券余汝意,聂媛媛1.562.222.812025-04-24
信达证券唐爱金1.611.972.402025-04-24
TOP↑